Canagliflozin compared with sitagliptin for patients with type 2 diabetes who do not have adequate glycemic control with metformin plus sulfonylurea: a 52-week randomized trial. Diabetes Care 2013;36:2508-2515

G. Schernthaner; J. Gross; J. Rosenstock; M. Guarisco; M. Fu; J. Yee; M. Kawaguchi; W. Canovatchel; G. Meininger

doi:10.2337/dc13-er12a

Canagliflozin compared with sitagliptin for patients with type 2 diabetes who do not have adequate glycemic control with metformin plus sulfonylurea: a 52-week randomized trial. Diabetes Care 2013;36:2508-2515

Diabetes Care ◽

10.2337/dc13-er12a ◽

2013 ◽

Vol 36 (12) ◽

pp. 4172-4172 ◽

Cited By ~ 2

Author(s):

G. Schernthaner ◽

J. Gross ◽

J. Rosenstock ◽

M. Guarisco ◽

M. Fu ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Randomized Trial ◽

Diabetes Care

Download Full-text

Comment on: Bosi et al. Intensive Structured Self-Monitoring of Blood Glucose and Glycemic Control in Noninsulin-Treated Type 2 Diabetes: The PRISMA Randomized Trial. Diabetes Care 2013;36:2887-2894

Diabetes Care ◽

10.2337/dc13-1394 ◽

2013 ◽

Vol 36 (12) ◽

pp. e217-e217

Author(s):

N. Kleefstra ◽

S. J. J. Logtenberg ◽

H. J. G. Bilo

Keyword(s):

Type 2 Diabetes ◽

Blood Glucose ◽

Glycemic Control ◽

Randomized Trial ◽

Diabetes Care ◽

Self Monitoring

Download Full-text

Response to Comment on: Bosi et al. Intensive Structured Self-Monitoring of Blood Glucose and Glycemic Control in Noninsulin-Treated Type 2 Diabetes: The PRISMA Randomized Trial. Diabetes Care 2013;36:2887-2894

Diabetes Care ◽

10.2337/dc13-1683 ◽

2013 ◽

Vol 36 (12) ◽

pp. e218-e218 ◽

Cited By ~ 1

Author(s):

E. Bosi ◽

M. Scavini ◽

A. Ceriello ◽

D. Cucinotta ◽

A. Tiengo ◽

...

Keyword(s):

Type 2 Diabetes ◽

Blood Glucose ◽

Glycemic Control ◽

Randomized Trial ◽

Diabetes Care ◽

Self Monitoring

Download Full-text

Response to Comment on Rosenstock et al. Impact of a Weekly Glucagon-Like Peptide 1 Receptor Agonist, Albiglutide, on Glycemic Control and on Reducing Prandial Insulin Use in Type 2 Diabetes Inadequately Controlled on Multiple Insulin Therapy: A Randomized Trial. Diabetes Care 2020;43:2509–2518

Diabetes Care ◽

10.2337/dci21-0004 ◽

2021 ◽

Vol 44 (11) ◽

pp. e196-e197

Author(s):

Julio Rosenstock

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Insulin Therapy ◽

Randomized Trial ◽

Diabetes Care ◽

Receptor Agonist ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Insulin Use

Download Full-text

Comment on Rosenstock et al. Impact of a Weekly Glucagon-Like Peptide 1 Receptor Agonist, Albiglutide, on Glycemic Control and on Reducing Prandial Insulin Use in Type 2 Diabetes Inadequately Controlled on Multiple Insulin Therapy: A Randomized Trial. Diabetes Care 2020;43:2509–2518

Diabetes Care ◽

10.2337/dc20-2987 ◽

2021 ◽

Vol 44 (11) ◽

pp. e194-e195 ◽

Cited By ~ 1

Author(s):

Chinmay S. Marathe ◽

Karen L. Jones ◽

Christopher K. Rayner ◽

Tongzhi Wu ◽

Michael Horowitz

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Insulin Therapy ◽

Randomized Trial ◽

Diabetes Care ◽

Receptor Agonist ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Insulin Use

Download Full-text

Response to Comment on Grimaldi et al. Association of Obstructive Sleep Apnea in Rapid Eye Movement Sleep With Reduced Glycemic Control in Type 2 Diabetes: Therapeutic Implications. Diabetes Care 2014;37:355–363

Diabetes Care ◽

10.2337/dc13-2662 ◽

2014 ◽

Vol 37 (3) ◽

pp. e60-e61 ◽

Cited By ~ 1

Author(s):

Babak Mokhlesi ◽

Daniela Grimaldi ◽

Eve Van Cauter

Keyword(s):

Type 2 Diabetes ◽

Obstructive Sleep Apnea ◽

Sleep Apnea ◽

Glycemic Control ◽

Eye Movement ◽

Diabetes Care ◽

Rapid Eye Movement Sleep ◽

Therapeutic Implications ◽

Obstructive Sleep

Download Full-text

Factors associated with improved glycemic control following continuous subcutaneous insulin infusion therapy in patients with type 2 diabetes uncontrolled with bolus-basal insulin regimens: An analysis from the OpT2mise randomized trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.12960 ◽

2017 ◽

Vol 19 (10) ◽

pp. 1490-1494 ◽

Cited By ~ 7

Author(s):

Muriel Metzger ◽

Javier Castañeda ◽

Yves Reznik ◽

Francesco Giorgino ◽

Ignacio Conget ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Randomized Trial ◽

Basal Insulin ◽

Continuous Subcutaneous Insulin Infusion ◽

Insulin Infusion ◽

Infusion Therapy ◽

Subcutaneous Insulin ◽

Factors Associated

Download Full-text

Response to Comment on Laiteerapong et al. The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications (The Diabetes & Aging Study). Diabetes Care 2019;42:416–426

Diabetes Care ◽

10.2337/dci18-0036 ◽

2019 ◽

Vol 42 (3) ◽

pp. e46-e47

Author(s):

Neda Laiteerapong ◽

Sandra A. Ham ◽

Elbert S. Huang ◽

Andrew J. Karter

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Diabetes Care ◽

Legacy Effect ◽

Aging Study

Download Full-text

Hypoglycemia, intensive glycemic control and diabetes care in care home residents with Type 2 diabetes

Aging Health ◽

10.2217/ahe.09.81 ◽

2010 ◽

Vol 6 (1) ◽

pp. 31-40 ◽

Cited By ~ 1

Author(s):

Siobhan HM Brown ◽

Ahmed H Abdelhafiz

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Diabetes Care ◽

Care Home ◽

Intensive Glycemic Control

Download Full-text

Response to Comment on Nauck et al. Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial. Diabetes Care 2019;42:1912–1920

Diabetes Care ◽

10.2337/dci19-0067 ◽

2020 ◽

Vol 43 (2) ◽

pp. e30-e31 ◽

Cited By ~ 1

Author(s):

Michael A. Nauck ◽

Eskil Kreiner ◽

Søren Rasmussen ◽

Hans A. Saevereid ◽

John B. Buse

Keyword(s):

Type 2 Diabetes ◽

High Risk ◽

Randomized Trial ◽

Diabetes Care ◽

Cardiovascular Events ◽

Biliary Disease

Download Full-text

Comment on Zhang et al. Second-Line Agents for Glycemic Control for Type 2 Diabetes: Are Newer Agents Better? Diabetes Care 2014;37:1338–1345

Diabetes Care ◽

10.2337/dc14-0983 ◽

2014 ◽

Vol 37 (9) ◽

pp. e205-e205 ◽

Cited By ~ 1

Author(s):

Andrea Messori ◽

Alfonso Bellia

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Diabetes Care ◽

Second Line

Download Full-text